Steven W. King
Director · Oncotelic Therapeutics, Inc.
Individual
- 2026
- Jul 21, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Steven W. King files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vuong Trieu - $60K in OTLC purchases and sales in the last 12 months
- Amit B. Shah - $1K in OTLC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven W. King?
Steven W. King is a corporate insider, tracked as Director of Oncotelic Therapeutics, Inc. (OTLC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Steven W. King last file a Form 4?
The only primary Form 4 on record is dated 21 July 2026.